Recently added articles from Pharmaceutical Technology Europe:
News bites
Jan 01, 2009; ... Pilot plant for Recipharm Under the terms of a new agreement, Recipharm Biotech AB (Sweden) will lease the AstraZeneca Biotech Laboratory (ABL), allowing Recipharm to expand its service offerings with mammalian recombinant protein and monoclonal antibody development and production ...
New beginnings
Jan 01, 2009; ... A new year, all things being equal, is a time of looking to the future with positive intent and traditional bonhomie. At the very least, it suggests new beginnings. As we enter 2009, however, the world is moving into a major recession and things are far from equal. As an Industry, ...
Happy 2009!
Jan 01, 2009; ... Christmas is over. Everybody is back at work feeling a bit hungover, a lot poorer and alarmingly heavier. We have all enjoyed time with our families, made wonderful 'New Year resolutions' that we are sure to have forgotten in less than 10 days and exchanged gossip about the office Christmas ...
The four colours of biotechnology
Jan 01, 2009; ... The biotechnology sector is occasionally described as a rainbow, with each sub sector having its own colour. But what do the different colours of biotechnology have to offer the pharmaceutical industry? The UK Government has decided there might be money in biotechnology. As well as this, ...
Pharma must speed up transformation
Jan 01, 2009; ... With the threat of a broad recession looming, leaders of the largest global pharmaceutical companies must act swiftly to ensure sustained growth, according to Ernst & Young's biannual pharmaceutical report. The industry currently faces a barrage of challenges because of imminent patent ...
The tough road for US pharma
Jan 01, 2009; ... How will the world's most dominant pharmaceutical market fare under the new US presidency? The US remains the dominant market for pharmaceutical manufacturers as it represents more than 40% of the global market.1-2 A major attraction for pharmaceutical companies is the reluctance of the ...
Hot-melt extrusion: an emerging drug delivery technology
Jan 01, 2009; ... Hot-melt extrusion offers many advantages compared with conventional solid dosage form manufacturing, and has consequently received considerable attention from both the pharmaceutical industry and academia as a novel drug delivery technology. The possibility of forming solid dispersions with ...
TECHNOLOGY MARKET
Jan 01, 2009; ... UV transmittance analyser The TX Online UV transmittance analyser, available from Hanovia, accurately monitors UV water disinfection systems. A unique feature of the device is an ultrasonic cleaning system that keeps the optical chamber clean at all times. Additionally, a bubble ...
TECHNOLOGY UPDATE
Jan 01, 2009; ... Machine vision systems A sophisticated camera-based recognition system, available from Vitronic, verifies batch numbers, dosage directions, expiry dates and safety information on drug containers in automated pharmaceutical production lines. As boxes, blisters and packets flow through the ...
PACKAGING AND LABELLING EQUIPMENT
Jan 01, 2009; ... Editor's product of the month Sorbent dispenser Multisorb offers its compact, state-of-the-art sorbent dispenser. Two servo-driven dispensing heads mounted on a single chassis mean the APA-4000 is capable of speeds up to 600 packages/ min while constant flow for continuous ...
BIO NEWS: News bites
Jan 01, 2009; ... Eden's millions Despite the turbulent marketing conditions. Eden Biodesign says three separate contracts have been signed, worth an initial total value of euro3.48 million. Two of the contracts are with new clients; one based in Asia and the other in Continental Europe. All the signed ...
Sustainability in green pharmaceutical production
Jan 01, 2009; ... Reducing ecological footprint and achieving more sustainable production of pharmaceuticals could help create a better future. That it requires considerable efforts in R&D of green processes for the manufacturing of green antibiotics is not the main problem; the biggest challenge comes in the ...
BIO SHOWCASE
Jan 01, 2009; ... Editor's product of the month Label-free interaction analysis system Utilizing novel resonant acoustic profiling technology, TTP LabTech's RAPid 4 is a flow-based analysis system that performs label-free interaction analysis. The system exploits the piezoelectric effects of ...
Biotech heads for the Alps
Jan 01, 2009; ... A European Initiative hopes to unite research, industrial and training resources in the biotech and medtech sectors by creating the 'Alps Bio Cluster' over an extended transalpine area. The partners involved in the project- six transalpine regions representing five European countries; France, ...
Zapping toxins!
Jan 01, 2009; ... Researchers have shown that a mild electric field can successfully extract unwanted by-product chemicals from a bioreactor, which should enable mammalian cell bioreactors to run at higher cell densities and bring down the cost of manufacturing. The breakthrough was made by researchers at EKB ...
Organizational polygamy
Jan 01, 2009; ... Paul Gardiner and Andrea Sobrio explain why most companies need 'organizational polygamy' to maximize profit and best serve their customers. Traditionally, pharmaceutical organizations consist of small global and regional organizations and large, autonomous affiliate organizations. While ...
Promoting a peaceful workplace
Jan 01, 2009; ... Conflict between departments costs money, wastes time and hinders strategy implementation. But we can reduce it and manage it if we understand it, says Dr Brian D. Smith. Sometimes, the eyes really are the window of an executive's soul. As one sat across from me and told me how her ...
Understanding rejection
Jan 01, 2009; ... How do our bodies reject some of the drugs sent to cure us? This biological mystery could soon be answered by a physicist and a mathematical modeller from two UK universities who aim to find out why and how the molecules that oppose drug entry into cells work. "We will be working at the ...
Pfizer's UK warning
Jan 01, 2009; ... Pfizer has taken action against counterfeits by giving a public warning to men about the dangers of buying pharmaceuticals using the internet. According to a report commissioned by the pharma giant, one in ten men interviewed in the UK admitted to purchasing prescription-only medicines ...
Pulling the plug
Dec 01, 2008; ... industry Trials involving marketed therapies are more likely to be terminated Clinical trials terminated because of poor enrollment are four times more likely to involve a marketed therapy than a novel drug, according to research published in the Good Clinical Practice Journal ....